These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25528116)

  • 1. Free fatty acids enhance the oxidative damage induced by ethanol metabolism in an in vitro model.
    Hernández I; Domínguez-Pérez M; Bucio L; Souza V; Miranda RU; Clemens DL; Gomez-Quiroz LE; Gutiérrez-Ruiz MC
    Food Chem Toxicol; 2015 Feb; 76():109-15. PubMed ID: 25528116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evidence for chronic alcohol and high glucose mediated increased oxidative stress and hepatotoxicity.
    Chandrasekaran K; Swaminathan K; Mathan Kumar S; Clemens DL; Dey A
    Alcohol Clin Exp Res; 2012 Jun; 36(6):1004-12. PubMed ID: 22309822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated glutathione level does not protect against chronic alcohol mediated apoptosis in recombinant human hepatoma cell line VL-17A over-expressing alcohol metabolizing enzymes--alcohol dehydrogenase and Cytochrome P450 2E1.
    Chandrasekaran K; Swaminathan K; Kumar SM; Chatterjee S; Clemens DL; Dey A
    Toxicol In Vitro; 2011 Jun; 25(4):969-78. PubMed ID: 21414402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of CYP2E1 leads to decreased malondialdehyde-acetaldehyde adduct formation in VL-17A cells under chronic alcohol exposure.
    Swaminathan K; Clemens DL; Dey A
    Life Sci; 2013 Mar; 92(6-7):325-36. PubMed ID: 23352969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of CYP2E1 leads to decreased advanced glycated end product formation in high glucose treated ADH and CYP2E1 over-expressing VL-17A cells.
    Swaminathan K; Kumar SM; Clemens DL; Dey A
    Biochim Biophys Acta; 2013 Oct; 1830(10):4407-16. PubMed ID: 23707663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic basis of ethanol-induced cytotoxicity in recombinant HepG2 cells: role of nonoxidative metabolism.
    Wu H; Cai P; Clemens DL; Jerrells TR; Ansari GA; Kaphalia BS
    Toxicol Appl Pharmacol; 2006 Oct; 216(2):238-47. PubMed ID: 16806343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Hep G2 cells that express alcohol dehydrogenase and cytochrome P450 2E1 as a model of ethanol-elicited cytotoxicity.
    Donohue TM; Osna NA; Clemens DL
    Int J Biochem Cell Biol; 2006 Jan; 38(1):92-101. PubMed ID: 16181800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor protects hepatocytes against oxidative injury induced by ethanol metabolism.
    Valdés-Arzate A; Luna A; Bucio L; Licona C; Clemens DL; Souza V; Hernandez E; Kershenobich D; Gutiérrez-Ruiz MC; Gómez-Quiroz LE
    Free Radic Biol Med; 2009 Aug; 47(4):424-30. PubMed ID: 19463946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GSH protects against oxidative stress and toxicity in VL-17A cells exposed to high glucose.
    Kumar SM; Swaminathan K; Clemens DL; Dey A
    Eur J Nutr; 2015 Mar; 54(2):223-34. PubMed ID: 24756473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethanol metabolism by alcohol dehydrogenase or cytochrome P
    Doody EE; Groebner JL; Walker JR; Frizol BM; Tuma DJ; Fernandez DJ; Tuma PL
    Am J Physiol Gastrointest Liver Physiol; 2017 Dec; 313(6):G558-G569. PubMed ID: 28864499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased oxidative stress and toxicity in ADH and CYP2E1 overexpressing human hepatoma VL-17A cells exposed to high glucose.
    Chandrasekaran K; Swaminathan K; Kumar SM; Clemens DL; Dey A
    Integr Biol (Camb); 2012 May; 4(5):550-63. PubMed ID: 22436864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress mediated toxicity exerted by ethanol-inducible CYP2E1.
    Wu D; Cederbaum AI
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):70-6. PubMed ID: 16019049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel small molecule, LAS-0811, inhibits alcohol-induced apoptosis in VL-17A cells.
    Kim TH; Venugopal SK; Zhu M; Wang SS; Lau D; Lam KS; Clemens DL; Zern MA
    Biochem Biophys Res Commun; 2009 Feb; 379(4):876-81. PubMed ID: 19133235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of cytochrome CYP2E1 as critical mediator of synergistic effects of alcohol and cellular lipid accumulation in hepatocytes in vitro.
    Mahli A; Thasler WE; Patsenker E; Müller S; Stickel F; Müller M; Seitz HK; Cederbaum AI; Hellerbrand C
    Oncotarget; 2015 Dec; 6(39):41464-78. PubMed ID: 26497211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of changes in glutathione levels through exogenous agents on intracellular cysteine content and protein adduct formation in chronic alcohol-treated VL17A cells.
    Kumar SM; Haridoss M; Swaminathan K; Gopal RK; Clemens D; Dey A
    Toxicol Mech Methods; 2017 Feb; 27(2):128-135. PubMed ID: 27915491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nrf2 and antioxidant defense against CYP2E1 toxicity.
    Cederbaum A
    Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1223-44. PubMed ID: 19671018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and properties of HepG2 cells that constitutively express CYP2E1.
    Wu D; Cederbaum AI
    Methods Mol Biol; 2008; 447():137-50. PubMed ID: 18369917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nrf2 and antioxidant defense against CYP2E1 toxicity.
    Cederbaum AI
    Subcell Biochem; 2013; 67():105-30. PubMed ID: 23400918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2E1-dependent toxicity and oxidative stress in HepG2 cells.
    Cederbaum AI; Wu D; Mari M; Bai J
    Free Radic Biol Med; 2001 Dec; 31(12):1539-43. PubMed ID: 11744327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress, toxicology, and pharmacology of CYP2E1.
    Caro AA; Cederbaum AI
    Annu Rev Pharmacol Toxicol; 2004; 44():27-42. PubMed ID: 14744237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.